| Dr Shilpa Bhardwaj, MD | |
|
6715 Mccrimmon Pkwy Ste 300, Cary, NC 27519-1916 | |
| (919) 481-4997 | |
| (919) 388-3271 |
| Full Name | Dr Shilpa Bhardwaj |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 6715 Mccrimmon Pkwy Ste 300, Cary, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013247493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2012-02329 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rex Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians Network | 5496940546 | 709 |
News Archive
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.
Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Kansas, South Dakota and Texas are among the states still making decisions - or reconsidering old ones - about the health law's insurance exchanges and the Medicaid expansion.
› Verified 4 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.
Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Kansas, South Dakota and Texas are among the states still making decisions - or reconsidering old ones - about the health law's insurance exchanges and the Medicaid expansion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shilpa Bhardwaj, MD 2000 Perimeter Park Dr Ste 200, Morrisville, NC 27560-8442 Ph: (984) 215-4110 | Dr Shilpa Bhardwaj, MD 6715 Mccrimmon Pkwy Ste 300, Cary, NC 27519-1916 Ph: (919) 481-4997 |
News Archive
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.
Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Kansas, South Dakota and Texas are among the states still making decisions - or reconsidering old ones - about the health law's insurance exchanges and the Medicaid expansion.
› Verified 4 days ago
Mrs. Novlet Jarrett Davis, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 875 Walnut St # 275-9, Cary, NC 27511 Phone: 919-749-6288 Fax: 919-443-1268 | |
Mohammad Saeed Anwar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 New Edition Ct, Cary, NC 27511 Phone: 919-568-1600 Fax: 919-650-3039 | |
Dr. Scott Carter Bilbro, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 530 New Waverly Pl, Suite 200, Cary, NC 27511 Phone: 919-859-5955 Fax: 919-859-5659 | |
Harishchandra Mahaseth, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 Kilmayne Dr Ste A, Cary, NC 27511 Phone: 919-467-2253 | |
Sheila A. Shine, N.P. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Ashville Ave, Ste 310, Cary, NC 27518 Phone: 919-233-8585 Fax: 919-233-8566 | |
Dr. Byron Kenneth Cole, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Hickorywood Blvd., Cary, NC 27519 Phone: 919-468-9960 |